{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:47:35Z","timestamp":1790398055355,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100004361","name":"Krebsliga Schweiz","doi-asserted-by":"publisher","award":["KLS-3384-02-2014-R"],"award-info":[{"award-number":["KLS-3384-02-2014-R"]}],"id":[{"id":"10.13039\/501100004361","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12885-017-3054-6","type":"journal-article","created":{"date-parts":[[2017,1,19]],"date-time":"2017-01-19T10:43:44Z","timestamp":1484822624000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Tracking the origin of simultaneous endometrial and ovarian cancer by next-generation sequencing \u2013 a case report"],"prefix":"10.1186","volume":"17","author":[{"given":"Nadejda","family":"Valtcheva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska M.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelia","family":"Noske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleftherios P.","family":"Samartzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Maria","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Bellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Fink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Moch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Rechsteiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin J.","family":"Dedes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Wild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,19]]},"reference":[{"issue":"7353","key":"3054_CR1","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","volume":"474","author":"Cancer Genome Atlas Research, N","year":"2011","unstructured":"Cancer Genome Atlas Research, N. Integrated genomic analyses of ovarian carcinoma. Nature. 2011;474(7353):609\u201315.","journal-title":"Nature"},{"issue":"7447","key":"3054_CR2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","volume":"497","author":"Cancer Genome Atlas Research, N","year":"2013","unstructured":"Cancer Genome Atlas Research, N, et al. Integrated genomic characterization of endometrial carcinoma. Nature. 2013;497(7447):67\u201373.","journal-title":"Nature"},{"issue":"3","key":"3054_CR3","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1365-2559.2009.03367.x","volume":"56","author":"N Singh","year":"2010","unstructured":"Singh N. Synchronous tumours of the female genital tract. Histopathology. 2010;56(3):277\u201385.","journal-title":"Histopathology"},{"issue":"1","key":"3054_CR4","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/modpathol.2013.107","volume":"27","author":"MK McConechy","year":"2014","unstructured":"McConechy MK, et al. Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles. Mod Pathol. 2014;27(1):128\u201334.","journal-title":"Mod Pathol"},{"issue":"1","key":"3054_CR5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1525-1438.2007.00975.x","volume":"18","author":"YC Chiang","year":"2008","unstructured":"Chiang YC, et al. Synchronous primary cancers of the endometrium and ovary. Int J Gynecol Cancer. 2008;18(1):159\u201364.","journal-title":"Int J Gynecol Cancer"},{"issue":"11","key":"3054_CR6","doi-asserted-by":"crossref","first-page":"4918","DOI":"10.1172\/JCI70354","volume":"123","author":"MC Haffner","year":"2013","unstructured":"Haffner MC, et al. Tracking the clonal origin of lethal prostate cancer. J Clin Invest. 2013;123(11):4918\u201322.","journal-title":"J Clin Invest"},{"issue":"9","key":"3054_CR7","doi-asserted-by":"crossref","first-page":"18824","DOI":"10.3390\/ijms140918824","volume":"14","author":"EP Samartzis","year":"2013","unstructured":"Samartzis EP, et al. ARID1A mutations and PI3K\/AKT pathway alterations in endometriosis and endometriosis-associated ovarian carcinomas. Int J Mol Sci. 2013;14(9):18824\u201349.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"3054_CR8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrclinonc.2010.216","volume":"8","author":"KJ Dedes","year":"2011","unstructured":"Dedes KJ, et al. Emerging therapeutic targets in endometrial cancer. Nat Rev Clin Oncol. 2011;8(5):261\u201371.","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"3054_CR9","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1006\/gyno.2001.6298","volume":"82","author":"A Shinohara","year":"2001","unstructured":"Shinohara A, et al. Cytoplasmic\/nuclear expression without mutation of exon 3 of the beta-catenin gene is frequent in the development of the neoplasm of the uterine cervix. Gynecol Oncol. 2001;82(3):450\u20135.","journal-title":"Gynecol Oncol"},{"issue":"6","key":"3054_CR10","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1158\/1078-0432.CCR-10-0540","volume":"17","author":"ML Rudd","year":"2011","unstructured":"Rudd ML, et al. A unique spectrum of somatic PIK3CA (p110alpha) mutations within primary endometrial carcinomas. Clin Cancer Res. 2011;17(6):1331\u201340.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"3054_CR11","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.cell.2014.03.027","volume":"157","author":"A Papa","year":"2014","unstructured":"Papa A, et al. Cancer-associated PTEN mutants act in a dominant-negative manner to suppress PTEN protein function. Cell. 2014;157(3):595\u2013610.","journal-title":"Cell"},{"issue":"6","key":"3054_CR12","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nrc1370","volume":"4","author":"K Pantel","year":"2004","unstructured":"Pantel K, Brakenhoff RH. Dissecting the metastatic cascade. Nat Rev Cancer. 2004;4(6):448\u201356.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"3054_CR13","doi-asserted-by":"crossref","first-page":"2006 e5-8","DOI":"10.1016\/j.fertnstert.2008.06.014","volume":"90","author":"G Corrado","year":"2008","unstructured":"Corrado G, et al. Progression of conservatively treated endometrial complex atypical hyperplasia in a young woman: a case report. Fertil Steril. 2008;90(5):2006 e5-8.","journal-title":"Fertil Steril"},{"key":"3054_CR14","doi-asserted-by":"crossref","unstructured":"Anglesio MS, et al. Synchronous Endometrial and Ovarian Carcinomas: Evidence of Clonality. J Natl Cancer Inst. 2016;108(6):djv428.","DOI":"10.1093\/jnci\/djv428"},{"key":"3054_CR15","doi-asserted-by":"crossref","unstructured":"Schultheis AM, et al. Massively Parallel Sequencing-Based Clonality Analysis of Synchronous Endometrioid Endometrial and Ovarian Carcinomas. J Natl Cancer Inst. 2016;108(6):djv427.","DOI":"10.1093\/jnci\/djv427"},{"key":"3054_CR16","doi-asserted-by":"crossref","unstructured":"Guan B, et al. Roles of deletion of Arid1a, a tumor suppressor, in mouse ovarian tumorigenesis. J Natl Cancer Inst, 2014;106(7):dju146.","DOI":"10.1093\/jnci\/dju146"},{"issue":"53","key":"3054_CR17","doi-asserted-by":"crossref","first-page":"53ra75","DOI":"10.1126\/scitranslmed.3001538","volume":"2","author":"KJ Dedes","year":"2010","unstructured":"Dedes KJ, et al. PTEN deficiency in endometrioid endometrial adenocarcinomas predicts sensitivity to PARP inhibitors. Sci Transl Med. 2010;2(53):53ra75.","journal-title":"Sci Transl Med"},{"issue":"14","key":"3054_CR18","doi-asserted-by":"crossref","first-page":"5295","DOI":"10.18632\/oncotarget.2092","volume":"5","author":"EP Samartzis","year":"2014","unstructured":"Samartzis EP, et al. Loss of ARID1A expression sensitizes cancer cells to PI3K- and AKT-inhibition. Oncotarget. 2014;5(14):5295\u2013303.","journal-title":"Oncotarget"},{"issue":"3","key":"3054_CR19","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nm.3799","volume":"21","author":"BG Bitler","year":"2015","unstructured":"Bitler BG, et al. Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers. Nat Med. 2015;21(3):231\u20138.","journal-title":"Nat Med"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-017-3054-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T15:06:36Z","timestamp":1568732796000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-017-3054-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,19]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["3054"],"URL":"https:\/\/doi.org\/10.1186\/s12885-017-3054-6","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,19]]},"article-number":"66"}}